Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Sirolimus × Gastrointestinal × Clear all

Phase

Status

Completed 18 Terminated 3 Unknown 2 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2 Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1 Gastrointestinal 1 Dermatologic 1

Conditions

Adenomatous Polyposis Coli 1

Interventions

Oxaliplatin 83 Capecitabine 52 Bevacizumab 52 Fluorouracil 44 Drug Therapy 39 Leucovorin 37 Gemcitabine 35 tislelizumab 33 Irinotecan 28 sintilimab 27 Cisplatin 23 lenvatinib 22 S 1 (combination) 20 Immune Checkpoint Inhibitors 20 toripalimab 17 irinotecan sucrosofate 17 apatinib 17 Surgical Procedures, Operative 17 Radiotherapy 17 HMPL-013 17 130-nm albumin-bound paclitaxel 17 Radiosurgery 16 Paclitaxel 15 Injections 15 camrelizumab 14 Folfox protocol 14 pembrolizumab 12 durvalumab 12 Immunotherapy 11 Specimen Handling 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06308445 2025-01-31

RAPA-4-PAF

University Hospital, Toulouse

Phase 2 Not yet recruiting

Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon ⚡